Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 19,342 | 10,701 | 12,251 | 15,902 | 23,720 |
| Cost of Goods | 3,279 | 4,400 | 2,715 | 2,879 | 1,444 |
| Gross Profit | 16,063 | 6,301 | 9,536 | 13,023 | 22,275 |
| Operating Expenses | 41,316 | 51,739 | 61,173 | 58,294 | 49,791 |
| Operating Income | -24,974 | -45,038 | -50,922 | -44,392 | -27,071 |
| Interest Expense | 7,680 | 7,027 | 6,262 | 5,664 | 5,599 |
| Other Income | 42 | 89 | 335 | 621 | 704 |
| Pre-tax Income | -32,612 | -51,976 | -56,849 | -49,436 | -31,967 |
| Net Income Continuous | -32,612 | -51,976 | -56,849 | -49,436 | -31,967 |
| Net Income | $-32,612 | $-51,976 | $-56,849 | $-49,436 | $-31,967 |
| EPS Basic Total Ops | -6.00 | -9.50 | -10.50 | -10.00 | -6.50 |
| EPS Basic Continuous Ops | -5.98 | -9.56 | -10.47 | -9.48 | -6.62 |
| EPS Diluted Total Ops | -6.00 | -9.50 | -10.50 | -10.00 | -6.50 |
| EPS Diluted Continuous Ops | -5.98 | -9.56 | -10.47 | -9.48 | -6.62 |
| EBITDA(a) | $-23,954 | $-44,347 | $-49,594 | $-43,963 | $-26,647 |